Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 1

1(20.0%)

Phase 2

1(20.0%)

5Total

N/A(3)

Phase 1(1)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT00227877Not ApplicableCompleted

Screening and Brief Advice to Reduce Teen Substance Use

Role: collaborator

NCT00849589Not ApplicableWithdrawn

Computerized Screening and Brief Physician Advice to Reduce Teen Drinking

Role: collaborator

NCT00907309Phase 1Completed

Dental and Medical Office iMET to Reduce Teen Tobacco, Alcohol, and Drug Use

Role: collaborator

NCT00611091Not ApplicableCompleted

Improving Posthospital Medication Management of Older Adults Through Health IT

Role: collaborator

NCT00053001Phase 2Completed

Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome

Role: lead

All 5 trials loaded